Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ShuRUXiaoJie Granules vs Xiaojin Pills for Breast Hyperplasia in Women in Northwest China
ChiCTR2400090501Phase 3Completed
- Sponsor
- Lanzhou Second People's Hospital
- Start
- Oct 2024
- Countries
- 1
01
Overview
Phase 3, randomised trial of shuruxiaojie in breast hyperplasia (2 arms), sponsored by Lanzhou Second People's Hospital. Primary endpoints: Pain Numeric Score, Chinese Medicine Symptom Score and 4 more. Started Oct 2024; status: completed.
02
Drugs
shuruxiaojie
03
Conditions
breast hyperplasia
Beyond the preview
Go deeper on ChiCTR2400090501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090501.